IAPP AIGP Practice Test 101
Question 1000
A customer-service company buys a managed generative API with terms allowing the vendor to reuse prompts for general model improvement. Postdeployment review has identified the same issue after a material service change. Which controlled response should follow an unsuccessful assurance test?
- Reject the unsupported employment use while suitable assessment and controls are missing.
- Shift to an approved fallback and isolate the old vendor connection if essential protections lapse.
- Suspend unsafe feature use and invoke contract remedies when material performance assurances fail.
- Stop sending protected prompts and move to a compliant service if terms cannot be controlled.
Explanation
Correct Answer
D:Stop sending protected prompts and move to a compliant service if terms cannot be controlled. Correct. It limits further reliance or exposure while the risk remains unresolved. Vendor AI contract terms can change the privacy and confidentiality risk of deployment.
Incorrect Answers
A:Reject the unsupported employment use while suitable assessment and controls are missing. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Predeployment impact reassessment: A vendor's original impact assessment does not cover every downstream purpose and population. The present case instead concerns Vendor data-use clauses.
B:Shift to an approved fallback and isolate the old vendor connection if essential protections lapse. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Supplier exit strategy: Third-party AI risk management includes practical exit and concentration resilience. The present case instead concerns Vendor data-use clauses.
C:Suspend unsafe feature use and invoke contract remedies when material performance assurances fail. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Vendor performance and SLA clauses: An infrastructure SLA alone is inadequate assurance for a consequential AI system. The present case instead concerns Vendor data-use clauses.
Question 1001
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. The operational owner must decide whether the current deployment can safely proceed. Which initial evidence check most directly addresses the governance concern?
- Review indemnities, liability caps, exclusions, claims procedures and jurisdiction-specific obligations.
- Compare the supplier's tested purpose and impact assessment with the new high-stakes employment use.
- Assess vendor concentration, portability, access continuity, model dependency and exit obligations.
- Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls.
Explanation
Correct Answer
D:Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls. Correct. It establishes the relevant factual risk boundary before implementation. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Review indemnities, liability caps, exclusions, claims procedures and jurisdiction-specific obligations. Not selected. That check primarily diagnoses a different governance issue. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
B:Compare the supplier's tested purpose and impact assessment with the new high-stakes employment use. Not selected. That check primarily diagnoses a different governance issue. It belongs with Predeployment impact reassessment: A vendor's original impact assessment does not cover every downstream purpose and population. The present case instead concerns Vendor performance and SLA clauses.
C:Assess vendor concentration, portability, access continuity, model dependency and exit obligations. Not selected. That check primarily diagnoses a different governance issue. It belongs with Supplier exit strategy: Third-party AI risk management includes practical exit and concentration resilience. The present case instead concerns Vendor performance and SLA clauses.
Question 1002
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. The operational owner must decide whether the current deployment can safely proceed. Which specific implementation best addresses the identified gap?
- Negotiate data-use restrictions and a permitted processing agreement consistent with approved business needs.
- Set a documented licensing compliance plan and approve redistribution only within permitted terms.
- Maintain end-to-end assurance and responsibility across model creation and deployment.
- Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement.
Explanation
Correct Answer
D:Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement. Correct. It directly reduces or governs the specific documented risk. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Negotiate data-use restrictions and a permitted processing agreement consistent with approved business needs. Not selected. That action treats another control objective, not the specific gap described. It belongs with Vendor data-use clauses: Vendor AI contract terms can change the privacy and confidentiality risk of deployment. The present case instead concerns Vendor performance and SLA clauses.
B:Set a documented licensing compliance plan and approve redistribution only within permitted terms. Not selected. That action treats another control objective, not the specific gap described. It belongs with Licensing and downstream rights: Open weights and permissive access do not mean there are no licensing obligations. The present case instead concerns Vendor performance and SLA clauses.
C:Maintain end-to-end assurance and responsibility across model creation and deployment. Not selected. That action treats another control objective, not the specific gap described. It belongs with Own-model development obligations: Owning a model increases control but also concentrates lifecycle and potential legal responsibilities. The present case instead concerns Vendor performance and SLA clauses.
Question 1003
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. The operational owner must decide whether the current deployment can safely proceed. Which acceptance test most directly verifies the relevant control?
- Run a tabletop scenario and confirm that contract obligations support timely notice and claim handling.
- Exercise a supplier failure scenario and verify continuity and secure data deletion.
- Review the release package for required notices and contractual restrictions.
- Test reporting and escalation using representative quality incidents rather than server outage alone.
Explanation
Correct Answer
D:Test reporting and escalation using representative quality incidents rather than server outage alone. Correct. It yields measurable evidence that the case-specific safeguard works. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Run a tabletop scenario and confirm that contract obligations support timely notice and claim handling. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
B:Exercise a supplier failure scenario and verify continuity and secure data deletion. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Supplier exit strategy: Third-party AI risk management includes practical exit and concentration resilience. The present case instead concerns Vendor performance and SLA clauses.
C:Review the release package for required notices and contractual restrictions. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Licensing and downstream rights: Open weights and permissive access do not mean there are no licensing obligations. The present case instead concerns Vendor performance and SLA clauses.
Question 1004
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. The operational owner must decide whether the current deployment can safely proceed. For a defensible decision, choose TWO: one diagnosis and one controlled response.
- Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement.
- Negotiate data-use restrictions and a permitted processing agreement consistent with approved business needs.
- Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls.
- Review indemnities, liability caps, exclusions, claims procedures and jurisdiction-specific obligations.
Explanation
Correct Answers
A:Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement. Correct. As the second, implementation half of the requested pair, this directly applies the needed safeguard. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
C:Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls. Correct. As the first, evidence-gathering half of the requested pair, this establishes the specific risk boundary. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
B:Negotiate data-use restrictions and a permitted processing agreement consistent with approved business needs. Not selected. It addresses a different governance mechanism, not the required assessment-and-control pair. It belongs with Vendor data-use clauses: Vendor AI contract terms can change the privacy and confidentiality risk of deployment. The present case instead concerns Vendor performance and SLA clauses.
D:Review indemnities, liability caps, exclusions, claims procedures and jurisdiction-specific obligations. Not selected. It addresses a different governance mechanism, not the required assessment-and-control pair. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
Question 1005
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. A new business unit wants to scale the system without a further governance review. Which diagnostic task establishes the risk relevant to this described system?
- Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls.
- Review indemnities, liability caps, exclusions, claims procedures and jurisdiction-specific obligations.
- Review model license, attribution, distribution limits, acceptable-use constraints and dataset rights.
- Compare the supplier's tested purpose and impact assessment with the new high-stakes employment use.
Explanation
Correct Answer
A:Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls. Correct. It establishes the relevant factual risk boundary before implementation. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
B:Review indemnities, liability caps, exclusions, claims procedures and jurisdiction-specific obligations. Not selected. That check primarily diagnoses a different governance issue. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
C:Review model license, attribution, distribution limits, acceptable-use constraints and dataset rights. Not selected. That check primarily diagnoses a different governance issue. It belongs with Licensing and downstream rights: Open weights and permissive access do not mean there are no licensing obligations. The present case instead concerns Vendor performance and SLA clauses.
D:Compare the supplier's tested purpose and impact assessment with the new high-stakes employment use. Not selected. That check primarily diagnoses a different governance issue. It belongs with Predeployment impact reassessment: A vendor's original impact assessment does not cover every downstream purpose and population. The present case instead concerns Vendor performance and SLA clauses.
Question 1006
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. A new business unit wants to scale the system without a further governance review. What is the strongest proportionate corrective design decision?
- Negotiate change-notice, data-return, deletion and service-transition provisions and test an alternative.
- Agree proportionate allocation of intellectual-property, security and incident cooperation duties with counsel.
- Set a documented licensing compliance plan and approve redistribution only within permitted terms.
- Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement.
Explanation
Correct Answer
D:Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement. Correct. It directly reduces or governs the specific documented risk. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Negotiate change-notice, data-return, deletion and service-transition provisions and test an alternative. Not selected. That action treats another control objective, not the specific gap described. It belongs with Supplier exit strategy: Third-party AI risk management includes practical exit and concentration resilience. The present case instead concerns Vendor performance and SLA clauses.
B:Agree proportionate allocation of intellectual-property, security and incident cooperation duties with counsel. Not selected. That action treats another control objective, not the specific gap described. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
C:Set a documented licensing compliance plan and approve redistribution only within permitted terms. Not selected. That action treats another control objective, not the specific gap described. It belongs with Licensing and downstream rights: Open weights and permissive access do not mean there are no licensing obligations. The present case instead concerns Vendor performance and SLA clauses.
Question 1007
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. A new business unit wants to scale the system without a further governance review. Which observable evidence best demonstrates the chosen safeguard is working?
- Audit the actual vendor settings and contract version against prohibited training or retention uses.
- Run a tabletop scenario and confirm that contract obligations support timely notice and claim handling.
- Review the release package for required notices and contractual restrictions.
- Test reporting and escalation using representative quality incidents rather than server outage alone.
Explanation
Correct Answer
D:Test reporting and escalation using representative quality incidents rather than server outage alone. Correct. It yields measurable evidence that the case-specific safeguard works. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Audit the actual vendor settings and contract version against prohibited training or retention uses. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Vendor data-use clauses: Vendor AI contract terms can change the privacy and confidentiality risk of deployment. The present case instead concerns Vendor performance and SLA clauses.
B:Run a tabletop scenario and confirm that contract obligations support timely notice and claim handling. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
C:Review the release package for required notices and contractual restrictions. Not selected. That test would not demonstrate this particular risk has been addressed. It belongs with Licensing and downstream rights: Open weights and permissive access do not mean there are no licensing obligations. The present case instead concerns Vendor performance and SLA clauses.
Question 1008
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. A new business unit wants to scale the system without a further governance review. A material exception remains unresolved. Which containment decision best protects affected parties?
- Shift to an approved fallback and isolate the old vendor connection if essential protections lapse.
- Suspend unsafe feature use and invoke contract remedies when material performance assurances fail.
- Freeze onboarding where material unallocated liabilities exceed accepted risk appetite.
- Stop sending protected prompts and move to a compliant service if terms cannot be controlled.
Explanation
Correct Answer
B:Suspend unsafe feature use and invoke contract remedies when material performance assurances fail. Correct. It limits further reliance or exposure while the risk remains unresolved. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Shift to an approved fallback and isolate the old vendor connection if essential protections lapse. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Supplier exit strategy: Third-party AI risk management includes practical exit and concentration resilience. The present case instead concerns Vendor performance and SLA clauses.
C:Freeze onboarding where material unallocated liabilities exceed accepted risk appetite. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Indemnity and liability allocation: Legal and commercial risk allocation requires scrutiny beyond marketing promises of responsible AI. The present case instead concerns Vendor performance and SLA clauses.
D:Stop sending protected prompts and move to a compliant service if terms cannot be controlled. Not selected. That response contains a different failure mode and leaves the stated risk unresolved. It belongs with Vendor data-use clauses: Vendor AI contract terms can change the privacy and confidentiality risk of deployment. The present case instead concerns Vendor performance and SLA clauses.
Question 1009
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. Postdeployment review has identified the same issue after a material service change. Before selecting a remedy, what should the accountable reviewer investigate first?
- Compare the supplier's tested purpose and impact assessment with the new high-stakes employment use.
- Review prompt retention, training reuse, subprocessors, transfer locations and deletion rights.
- Conduct a new context-specific impact assessment and obtain required safeguards before deployment.
- Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls.
Explanation
Correct Answer
D:Distinguish availability promises from clinical validity, monitoring access, performance reporting and change controls. Correct. It establishes the relevant factual risk boundary before implementation. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Compare the supplier's tested purpose and impact assessment with the new high-stakes employment use. Not selected. That check primarily diagnoses a different governance issue. It belongs with Predeployment impact reassessment: A vendor's original impact assessment does not cover every downstream purpose and population. The present case instead concerns Vendor performance and SLA clauses.
B:Review prompt retention, training reuse, subprocessors, transfer locations and deletion rights. Not selected. That check primarily diagnoses a different governance issue. It belongs with Vendor data-use clauses: Vendor AI contract terms can change the privacy and confidentiality risk of deployment. The present case instead concerns Vendor performance and SLA clauses.
C:Conduct a new context-specific impact assessment and obtain required safeguards before deployment. Not selected. This action relates to Predeployment impact reassessment. A vendor's original impact assessment does not cover every downstream purpose and population. For the diagnose decision, it does not resolve the specifically described issue of Vendor performance and SLA clauses in A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. Postdeployment review has identified the same issue after a material service change.
Question 1010
A hospital's AI vendor advertises 99.9% uptime but says nothing about model quality, bias drift or update notices. Postdeployment review has identified the same issue after a material service change. What action should the accountable team prioritize to govern this use responsibly?
- Set a documented licensing compliance plan and approve redistribution only within permitted terms.
- Negotiate change-notice, data-return, deletion and service-transition provisions and test an alternative.
- Negotiate data-use restrictions and a permitted processing agreement consistent with approved business needs.
- Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement.
Explanation
Correct Answer
D:Include measurable accuracy/safety thresholds, incident cooperation and material model-change notifications in the agreement. Correct. It directly reduces or governs the specific documented risk. An infrastructure SLA alone is inadequate assurance for a consequential AI system.
Incorrect Answers
A:Set a documented licensing compliance plan and approve redistribution only within permitted terms. Not selected. That action treats another control objective, not the specific gap described. It belongs with Licensing and downstream rights: Open weights and permissive access do not mean there are no licensing obligations. The present case instead concerns Vendor performance and SLA clauses.
B:Negotiate change-notice, data-return, deletion and service-transition provisions and test an alternative. Not selected. That action treats another control objective, not the specific gap described. It belongs with Supplier exit strategy: Third-party AI risk management includes practical exit and concentration resilience. The present case instead concerns Vendor performance and SLA clauses.
C:Negotiate data-use restrictions and a permitted processing agreement consistent with approved business needs. Not selected. That action treats another control objective, not the specific gap described. It belongs with Vendor data-use clauses: Vendor AI contract terms can change the privacy and confidentiality risk of deployment. The present case instead concerns Vendor performance and SLA clauses.